#USA #New York #Investor Rights #Wolf Haldenstein #Picard Medical

Class Action Lawsuit Against Picard Medical, Inc.

A recent class action lawsuit has been filed against Picard Medical, Inc. (NYSE: PMI), targeting shareholders who experienced financial losses. The law firm Wolf Haldenstein Adler Freeman & Herz LLP announced the lawsuit, inviting all individuals and entities that purchased or acquired shares of Picard from September 2, 2025, to October 31, 2025, to take action.

Details of the Class Action

Investors have until April 3, 2026, to seek appointments as lead plaintiffs in this class action. The complaint alleges that Picard Medical misled shareholders by providing false information and failing to disclose significant adverse facts about the company.

Among the allegations, the lawsuit claims that Picard was involved in a fraudulent stock promotion scheme utilizing social media misinformation. It raises concerns about insiders and affiliates allegedly using offshore accounts to facilitate the coordinated sale of shares during a time of price inflation. Moreover, it is asserted that the public statements made by Picard omitted vital information regarding false rumors and abnormal trading activities that influenced the stock price.

Why Contact Wolf Haldenstein?

Wolf Haldenstein has a long-standing reputation, founded in 1888, for advocating investor rights and pursuing justice for those who have been financially harmed by corporate misconduct. With over 125 years of legal expertise in securities litigation, the firm boasts a proven track record of success in similar cases.

The firm encourages all affected investors to reach out, especially those who may provide relevant information that could aid in the ongoing investigation regarding the conduct of Picard Medical. Interested shareholders are urged to contact the law firm directly for guidance on how to proceed with their claims.

Contact Information

For inquiries or to discuss potential participation in the lawsuit, individuals can reach out via phone at (800) 575-0735 or (212) 545-4774. Additionally, those wishing to connect via email can do so at [email protected], with Gregory Stone serving as the Director of Case and Financial Analysis.

As the deadline for filing a motion as lead plaintiff approaches, it’s critical for affected shareholders to act swiftly. Participating in a class action can provide a channel for recovery and ensure that corporate practices are held accountable.

Wolf Haldenstein is here to assist affected investors, providing legal expertise and support throughout the process. Don't miss this opportunity to seek the justice and compensation you deserve as a shareholder of Picard Medical, Inc.